Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00931905
Other study ID # 0632/02
Secondary ID
Status Completed
Phase Phase 4
First received June 30, 2009
Last updated July 31, 2009

Study information

Verified date July 2009
Source Federal University of São Paulo
Contact n/a
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Interventional

Clinical Trial Summary

Saturnism, or lead poisoning, is defined by clinical symptoms (affecting primarily the nervous, hematopoietic, gastrointestinal, cardiovascular, musculoskeletal, renal and reproductive systems) compatible with exposure, in the short or long term, to lead or to its compounds, and can manifest as acute or chronic symptoms, pursuant to the intensity and duration of the signs and symptoms. Measuring serum concentration is the primary method for diagnosing and accompanying exposed workers. Presently, elevated lead counts are reversed by using drugs whose effectiveness is contested on various fronts. Experimental studies shows the efficacy of homeopathic preparations in controlling blood lead levels in laboratory animals, creating the need for controlled studies that evaluate the effectiveness and safety of these preparations in humans.The objective of this study was evaluate the effectiveness of the homeopathic preparation Plumbum metallicum in reducing the blood lead level of workers exposed to this metal.


Recruitment information / eligibility

Status Completed
Enrollment 113
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- had not taken a leave of absence for any reason for a period greater than seven days in the 60 days prior to the intervention;

- where in good medical condition, as analyzed by their medical records and physical exam;

- had an initial blood lead level less than the maximum biological concentration permitted, which is 60ยต/dL in Brazil.

Exclusion Criteria:

- workers who, in the last six months, had used medication that interferes/d with the level of lead in the blood, such as EDTA, BAL, penicillinase and DMSA;

- workers who had the right to vacation during the study period;

- workers who did not give their consent to participate in the study.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Homeopathic medication Plumbum metallicum
The homeopathic medication Plumbum metallicum 15CH was used and was diluted and dynamized using the Hahnemann centesimal scale, whose matrix was obtained from the Schraiber laboratory in 4CH in 70% ethanol. From this solution, the matrix was elevated to 14CH in 70% ethanol. The 15CH dynamization was prepared in 30% ethanol, which was the recommended solution for administration.The drugs were administered orally (ten drops) twice daily - at the beginning and the end of the shift and under supervision for 30 days. The patients were instructed not to take other medication without medical guidance during the time they were participating in the research.
Other:
Hydroalcoholic solution
The placebo was composed of a hydroalcoholic solution also prepared in 30% ethanol. It was administered orally (ten drops) twice daily - at the beginning and the end of the shift and under supervision for 30 days. The patients were instructed not to take other medication without medical guidance during the time they were participating in the research.

Locations

Country Name City State
Brazil Universidade Federal de Sao Paulo Sao Paulo

Sponsors (1)

Lead Sponsor Collaborator
Federal University of São Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effectiveness of the homeopathic preparation Plumbum metallicum in treating poisoning with respect to the decrease of the blood lead level of workers exposed to lead. No
See also
  Status Clinical Trial Phase
Completed NCT01573013 - Iron Fortification Trail Using NaFeEDTA in Iron Deficient Lead-exposed Children N/A
Withdrawn NCT00552630 - Penicillamine Chelation for Children With Lead Poisoning Phase 2/Phase 3
Completed NCT00014885 - Bone Lead Levels and College Achievement Scores N/A
Completed NCT00004838 - Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned Children N/A
Enrolling by invitation NCT05265572 - Evaluation of the Impact of a Personal and Domestic Hygiene Intervention on Lead Exposure in a Community Close to a Mine Dump N/A
Completed NCT01739166 - QI Study of a Practice Facilitator's Impact in Working With Clinics on Improving Dental, Lead & Obesity Measures for Children N/A
Completed NCT00285610 - Early Exposure to Lead and Adult Antisocial Outcomes N/A
Completed NCT00011674 - Early Exposure to Lead and Adolescent Development N/A
Completed NCT00374894 - The Combined Effect of 2,3-Dimercaptosuccinic Acid and Multi-Nutrients on Children in Lead Poisoning N/A
Completed NCT00011661 - Social Network Based Intervention to Reduce Lead Exposure Among Native American Children N/A
Recruiting NCT03256383 - Plan for Testing Fingerstick Bloods on Magellan Systems N/A
Recruiting NCT05950386 - Effects of Lead Exposure on Ferroptosis Pathway
Completed NCT02346188 - Effects of Iron and/or Zinc Supplementation in Mexican School Children Exposed to Lead N/A
Completed NCT00013858 - Environmental Contaminants and Infant Development N/A
Completed NCT00013819 - Exposure, Dose, Body Burden and Health Effects of Lead N/A
Active, not recruiting NCT05744752 - Effects of Allium Sativum and Moringa Oleifera Extract on Dental Enamel N/A
Completed NCT00012480 - Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm N/A
Completed NCT00011726 - Lead Mobilization & Bone Turnover in Pregnancy/Lactation N/A
Completed NCT00023101 - Lead, Endocrine Disruption and Reproductive Outcomes N/A
Terminated NCT04498845 - RECLEAN Pilot Study N/A